Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lemborexant observational cohort in Alzheimer's disease with insomnia
ChiCTR2600132469Phase 4Not yet recruiting
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lemborexant in Insomnia, sponsored by Sir Run-Run Shaw Hospital. Primary endpoint: Insomnia Severity Index at month 6. Planned start May 2026; status: not yet recruiting.
02
Drugs
lemborexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on ChiCTR2600132469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600132469.